Hepatitis C virus infection and atherosclerotic cardiovascular disease: recent knowledge, further insights.
作者信息
Patoulias Dimitrios Ioannis, Kalogirou Maria-Styliani
机构信息
Second Propedeutic Department of Internal Medicine, General Hospital "Hippokration", Aristotle University of Thessaloniki, Thessaloniki, Greece.
出版信息
Clin Exp Hepatol. 2020 Feb;6(1):63-64. doi: 10.5114/ceh.2020.93060. Epub 2020 Feb 17.
Abstract
摘要
相似文献
1
Hepatitis C virus infection and atherosclerotic cardiovascular disease: recent knowledge, further insights.丙型肝炎病毒感染与动脉粥样硬化性心血管疾病：最新认知与进一步见解
Clin Exp Hepatol. 2020 Feb;6(1):63-64. doi: 10.5114/ceh.2020.93060. Epub 2020 Feb 17.
2
Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.合并队列动脉粥样硬化性心血管疾病风险评分在丙型肝炎病毒感染者中的表现。
J Viral Hepat. 2017 Oct;24(10):814-822. doi: 10.1111/jvh.12705. Epub 2017 Apr 10.
3
HIV, Cocaine Use, and Hepatitis C Virus: A Triad of Nontraditional Risk Factors for Subclinical Cardiovascular Disease.人类免疫缺陷病毒、可卡因使用与丙型肝炎病毒：亚临床心血管疾病的非传统三联危险因素
Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2100-7. doi: 10.1161/ATVBAHA.116.307985. Epub 2016 Sep 8.
4
Atherosclerosis as a possible extrahepatic manifestation of chronic hepatitis C virus infection.动脉粥样硬化作为慢性丙型肝炎病毒感染可能的肝外表现。
Clin Med Insights Cardiol. 2014 Nov 12;8(Suppl 3):1-5. doi: 10.4137/CMC.S17069. eCollection 2014.
5
Cardiovascular disease and hepatitis C virus infection: an irrelevant statement or a hot relationship?心血管疾病与丙型肝炎病毒感染：无关之谈还是紧密关联？
Cardiol Rev. 2015 Jan-Feb;23(1):11-7. doi: 10.1097/CRD.0000000000000031.
6
Antiviral treatment does not improve subclinical atheromatosis in patients with chronic hepatitis caused by hepatitis C virus.抗病毒治疗并不能改善丙型肝炎病毒引起的慢性肝炎患者的亚临床动脉粥样硬化。
Gastroenterol Hepatol. 2019 Jun-Jul;42(6):362-371. doi: 10.1016/j.gastrohep.2019.02.002. Epub 2019 Apr 2.
7
Non-atherosclerotic cardiac manifestations of chronic hepatitis C virus infection in the era of direct-acting antiviral agents.直接作用抗病毒药物时代慢性丙型肝炎病毒感染的非动脉粥样硬化性心脏表现
Atherosclerosis. 2020 Apr;298:70. doi: 10.1016/j.atherosclerosis.2020.02.021. Epub 2020 Mar 2.
8
Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor?慢性丙型肝炎病毒感染：一种新的可改变的心脏代谢危险因素？
Clujul Med. 2017;90(3):251-255. doi: 10.15386/cjmed-793. Epub 2017 Jul 15.
9
Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis.直接作用抗病毒药物清除丙型肝炎病毒可改善严重肝纤维化患者的颈动脉粥样硬化。
J Hepatol. 2018 Jul;69(1):18-24. doi: 10.1016/j.jhep.2018.02.015. Epub 2018 Mar 2.
10
Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model.嗜肝DNA病毒感染的隐匿性持续存在及嗜淋巴细胞性：来自土拨鼠病毒性肝炎模型的见解
Immunol Rev. 2000 Apr;174:98-111. doi: 10.1034/j.1600-0528.2002.017406.x.
本文引用的文献
1
Prevalence of hepatitis C virus infection in patients hospitalised for ischemic heart disease versus controls - PRO-CARDIO-C study.缺血性心脏病住院患者与对照组中丙型肝炎病毒感染的患病率 - PRO-CARDIO-C研究
Clin Exp Hepatol. 2019 May;5(2):118-122. doi: 10.5114/ceh.2019.84782. Epub 2019 Apr 30.
2
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study.慢性丙型肝炎患者在应用直接抗病毒药物前的长期应答者的临床结局：一项单中心回顾性研究。
Minerva Med. 2019 Oct;110(5):401-409. doi: 10.23736/S0026-4806.19.06108-1. Epub 2019 May 6.
3
Hepatitis C virus infection and risk of coronary artery disease: A meta-analysis.丙型肝炎病毒感染与冠状动脉疾病风险：一项荟萃分析。
Eur J Intern Med. 2019 May;63:69-73. doi: 10.1016/j.ejim.2019.03.004. Epub 2019 Apr 18.
4
Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events.直接作用抗病毒疗法治疗丙型肝炎感染可降低心血管疾病事件风险。
Gastroenterology. 2019 Mar;156(4):987-996.e8. doi: 10.1053/j.gastro.2018.11.022. Epub 2018 Nov 13.
5
Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013.2004-2013 年慢性肝脏疾病导致的医疗保健负担日益加重，甚于其他慢性疾病。
Gastroenterology. 2018 Sep;155(3):719-729.e4. doi: 10.1053/j.gastro.2018.05.032. Epub 2018 May 23.
6
Comparison of cardiovascular outcomes and all-cause mortality in patients with chronic hepatitis B and C: A 13-year nationwide population-based study in Asia.比较亚洲慢性乙型肝炎和丙型肝炎患者的心血管结局和全因死亡率：一项为期 13 年的全国性基于人群的研究。
Atherosclerosis. 2018 Feb;269:178-184. doi: 10.1016/j.atherosclerosis.2018.01.007. Epub 2018 Jan 12.
7
HIV/HCV coinfection and the risk of cardiovascular disease: A meta-analysis.人类免疫缺陷病毒/丙型肝炎病毒合并感染与心血管疾病风险：一项荟萃分析。
J Viral Hepat. 2017 Nov;24(11):998-1004. doi: 10.1111/jvh.12725. Epub 2017 Jun 23.
8
The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis.丙型肝炎患者患冠状动脉疾病和脑血管疾病的风险：一项系统评价和荟萃分析。
Int J Cardiol. 2016 Oct 15;221:746-54. doi: 10.1016/j.ijcard.2016.06.337. Epub 2016 Jul 4.
9
Comparison of Angiographic Burden of Coronary Artery Disease in Patients With Versus Without Hepatitis C Infection.丙型肝炎感染患者与未感染患者冠状动脉疾病血管造影负担的比较。
Am J Cardiol. 2015 Oct 1;116(7):1041-4. doi: 10.1016/j.amjcard.2015.06.035. Epub 2015 Jul 16.
10
Higher Prevalence and More Severe Coronary Artery Disease in Hepatitis C Virus-infected Patients: A Case Control Study.丙型肝炎病毒感染患者中冠状动脉疾病的更高患病率和更严重程度：一项病例对照研究。
J Clin Exp Hepatol. 2013 Sep;3(3):186-91. doi: 10.1016/j.jceh.2013.05.004. Epub 2013 Jun 11.
Zotero 插件